Two Health Economic Analysis

1 min read /
Allergy

Atopic dermatitis (AD) or eczema places a significant economic burden on the healthcare system and patient’s families. Two health economic analysis

Save (for later)

Atopic dermatitis (AD) or eczema places a significant economic burden on the healthcare system and patient’s families. Two health economic analysis were performed in France and Spain to determine costs, consequences and cost-effectiveness of 100% whey-based partially- hydrolized formula as compared to standard formula and extensively hydrolyzed formula in the risk reduction of AD in “at risk” infants who are not breastfeed. The results calculated from different perspectives can be read in the two posters.

Articles

Default publication

Clinical and Economic Impact of a Partially Hydrolyzed Formula in the Prevention of Atopic Dermatitis in Spanish Children

Default publication

Clinical and Economic Impact of a Partially Hydrolyzed Formula in the Prevention of Atopic Dermatitis in French Children

Co-Authored by 8 Experts

If you liked this post you may also like

Please log in to your profile so we can show recommended content.